Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid use and adverse drug reactions in Belgian hospitals
2020-005772-35Phase 4Completed
- Sponsor
- UCLouvain
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linezolid in bacterial disease, sponsored by UCLouvain. Primary endpoint: Number of adverse drug reactions developed during linezolid treatment. Started Feb 2021; status: completed.
02
Drugs
linezolid
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2020-005772-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005772-35.